- Home
- PHVS vs RQI Comparison
PHVS vs RQI Comparison
Compare PHVS & RQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PHVS | RQI |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PHVS | RQI |
|---|---|---|
| Price | $29.73 | $12.21 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $40.70 | N/A |
| AVG Volume (30 Days) | 155.6K | ★ 346.1K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.20% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.51 | $10.39 |
| 52 Week High | $29.80 | $13.39 |
Technical Indicators
Market Signals| Indicator | PHVS | RQI |
|---|---|---|
| Relative Strength Index (RSI) | 65.28 | 46.09 |
| Support Level | $24.55 | $12.14 |
| Resistance Level | $29.80 | $12.65 |
| Average True Range (ATR) | 1.34 | 0.21 |
| MACD | 0.32 | -0.03 |
| Stochastic Oscillator | 91.13 | 47.93 |
Price Performance
Historical ComparisonAbout PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About RQI Cohen & Steers Quality Income Realty Fund Inc
COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the fund is high current income through investment in real estate securities. Its secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.